I disagree. I think there is a near 100% certainty that FY2009 will be cash flow positive, without factoring in the minimal BARDA revenues. BARDA is very important to the company, but not for the minimal revenues it generates. It is important for the huge costs it covers, and for the scientific data it generates.
- Forums
- ASX - By Stock
- PNV
- Polynovo’s Novosorb is a med-tech Swiss Army Knife
Polynovo’s Novosorb is a med-tech Swiss Army Knife, page-18
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PNV (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.42 |
Change
-0.050(2.02%) |
Mkt cap ! $1.670B |
Open | High | Low | Value | Volume |
$2.40 | $2.45 | $2.35 | $3.794M | 1.575M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2112 | $2.41 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.42 | 27096 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2112 | 2.410 |
1 | 2112 | 2.400 |
1 | 2112 | 2.390 |
2 | 6112 | 2.380 |
3 | 25612 | 2.370 |
Price($) | Vol. | No. |
---|---|---|
2.430 | 2112 | 1 |
2.440 | 6510 | 2 |
2.450 | 4201 | 2 |
2.460 | 3122 | 2 |
2.470 | 1802 | 1 |
Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |